Showing results (21-30 of 229) with videos related to

Sort By:
Pageof 23
Archives of Gynecology and Obstetrics|March 3, 2007
HPV induced ovarian squamous cell carcinoma: case report and review of the literatureJ Verguts, F Amant, Ph Moerman, et al.
Facts, Views & Vision in Obgyn|April 22, 2015
Immunological parameters as a new lead in the diagnosis of ovarian cancerT Baert, D Timmerman, I Vergote, et al.
European Journal of Gynaecological Oncology|February 12, 1999
Anaplastic nodules in an ovarian mucinous tumor. Case report and literature reviewH Hellemans, P Moerman, D Timmerman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma?E Despierre, P Moerman, I Vergote, et al.
Expert Review of Clinical Immunology|May 3, 2014
Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignanciesA Coosemans, I Vergote, S W Van Gool
Gynecologic Oncology|October 5, 2001
Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125F Amant, C Gabriel, D Timmerman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomasC Tropé, J Kaern, I Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 29, 2006
Second case of uterine mesonephric adenocarcinomaA Marquette, P Moerman, I Vergote, et al.
Cancer|September 1, 1989
A randomized trial of adjuvant progestagen in early endometrial cancerI Vergote, K Kjørstad, V Abeler, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 1, 1983
Dysgerminoma of the ovary in association with XY gonadal dysgenesisI Vergote, V Dieleman, D Becquart, et al.
Pageof 23